-
1Academic Journal
المؤلفون: Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, E. A. Ionova, S. E. Arakelov, I. Yu. Titova, A. Yu. Efimtsev, A. R. Meltonyan
المصدر: Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 14, Iss 2, Pp 111-122 (2024)
مصطلحات موضوعية: ultrasound, computed tomography, magnetic resonance imaging, steatosis, fibrosis, hemochromatosis, Medicine (General), R5-920
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, A. Yu. Efimtsev, S. E. Arakelov, I. Yu. Titova, A. R. Meltonyan
المصدر: Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 14, Iss 1, Pp 159-167 (2024)
مصطلحات موضوعية: chronic liver diseases, magnetic resonance imaging, biomarker, proton density of fat fraction, r2* of water, fatty hepatosis, fibrosis, cirrhosis, Medicine (General), R5-920
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: A. Yu. Babenko, M. Yu. Laevskaya, A. R. Meltonian, Yu. N. Savchenkov, G. E. Trufanov, А. Ю. Бабенко, М. Ю. Лаевская, А. Р. Мелтонян, Ю. Н. Савченков, Г. Е. Труфанов
المساهمون: The study was carried out with the support of the following source: State assignment No. 44, registration number 122041900080-5., Исследование выполнено при поддержке следующего источника: государственное задание № 44, регистрационный номер 122041900080-5.
المصدر: Translational Medicine; Том 10, № 3 (2023); 146-153 ; Трансляционная медицина; Том 10, № 3 (2023); 146-153 ; 2410-5155 ; 2311-4495
مصطلحات موضوعية: фиброз, fibrosis, magnetic resonance imaging, non-alcoholic fatty liver disease, steatosis, type 2 diabetes, ultrasound, неалкогольная жировая болезнь печени, сахарный диабет 2 типа, стеатоз, ультразвуковое исследование
وصف الملف: application/pdf
Relation: https://transmed.almazovcentre.ru/jour/article/view/849/511; Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183:109119. DOI:10.1016/j.diabres.2021.109119.; Yuan S, Chen J, Li X, et al. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study. Eur J Epidemiol. 2022; 37(7):723–733. DOI:10.1007/s10654-022-00868-3; Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7(9):851–861. DOI:10.1016/S2468-1253(22)00165-0; Younossi ZM. Non-alcoholic fatty liver disease — A global public health perspective. J Hepatol. 2019; 70(3):531–544. DOI:10.1016/j.jhep.2018.10.033.; Stine JG, Wentworth BJ, Zimmet A, et al. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018; 48(7):696–703. DOI:10.1111/apt.14937.; Targher G, Corey KE, Byrne CD, et al. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021; 18(9):599–612. DOI:10.1038/s41575-021-00448-y.; Shetty AS, Sipe AL, Zulfiqar M, et al. In-Phase and Opposed-Phase Imaging: Applications of Chemical Shift and Magnetic Susceptibility in the Chest and Abdomen. Radiographics. 2019; 39(1):115–135. DOI:10.1148/rg.2019180043.; Seifeldein GS, Hassan EA, Imam HM, et al. Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosis Egypt J Radiol Nucl Med. 2021; 52:210. DOI:10.1186/s43055-021-00590-2.; Диомидова В.Н., Тарасова Л.В., Цыганова Ю.В. и др. Ультразвуковая эластография печени с технологией затухающего сигнала позволяет оценить степень стеатоза и осуществлять динамическое наблюдение эффективности лечения НАЖБП. Экспе- риментальная и клиническая гастроэнтерология. 2020; (9):45–54. DOI:10.31146/1682-8658-ecg-181-9-45-54.; Ferraioli G, Soares Monteiro LB. Ultrasoundbased techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019; 25(40):6053–6062. DOI:10.3748/wjg.v25.i40.6053.; Ferraioli G, Berzigotti A, Barr RG, et al. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. Ultrasound Med Biol. 2021; 47(10):2803–2820. DOI:10.1016/j.ultrasmedbio.2021.06.002.; Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011; 54(3):1082–1090. DOI:10.1002/hep.24452.; Palmentieri B, de Sio I, La Mura V, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis. 2006; 38(7):485–489. DOI:10.1016/j.dld.2006.03.021.; Chan WK, Nik Mustapha NR, Mahadeva S, et al. Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis? J Gastroenterol Hepatol. 2018; 33(10):1787–1794. DOI:10.1111/jgh.14150.; Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009; 51(6):1061–1067. DOI:10.1016/j.jhep.2009.09.001.; Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol. 2017; 23(4):290–301. DOI:10.3350/cmh.2017.0042.; Hepburn MJ, Vos JA, Fillman EP, et al. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol. 2005; 5:14. DOI:10.1186/1471-230X-5-14.; Selvaraj EA, Mózes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021; 75(4):770–785. DOI:10.1016/j.jhep.2021.04.044.; Pu K, Wang Y, Bai S, et al. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterol. 2019; 19(1):51. DOI:10.1186/s12876-019-0961-9.; Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017; 66(5):1022–1030. DOI:10.1016/j.jhep.2016.12.022.; Hsu C, Caussy C, Imajo K, et al. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol. 2019; 17(4):630–637.e8. DOI:10.1016/j.cgh.2018.05.059.; Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology. 2017; 66(5):1486–1501. DOI:10.1002/hep.29302.; Anstee QM, Lawitz EJ, Alkhouri N, et al. Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. Hepatology. 2019; 70(5):1521–1530. DOI:10.1002/hep.30842.; Boursier J, Guillaume M, Leroy V, et al. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J Hepatol. 2019; 71(2):389–396. DOI:10.1016/j.jhep.2019.04.020.; Van Dijk AM, Vali Y, Mak AL, et al. Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease. J Clin Med. 2021; 10(13):2910. DOI:10.3390/jcm10132910.; Loong TC, Wei JL, Leung JC, et al. Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2017; 32(7):1363–1369. DOI:10.1111/jgh.13671.; Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall Med. 2017; 38(4):377–394. DOI:10.1055/s-0043-103955.; Piazzolla VA, Mangia A. Noninvasive Diagnosis of NAFLD and NASH. Cells. 2020; 9(4):1005. DOI:10.3390/cells9041005.; Ferraioli G, Tinelli C, Lissandrin R, et al. Ultrasound point shear wave elastography assessment of liver and spleen stiffness: effect of training on repeatability of measurements. Eur Radiol. 2014; 24(6):1283–1289. DOI:10.1007/s00330-014-3140-y.; Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med. 2017; 38(4):e16–e47. DOI:10.1055/s-0043-103952.; Jamialahmadi T, Nematy M, Jangjoo A, et al. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy. Obes Surg. 2019; 29(8):2585–2592. DOI:10.1007/s11695-019-03889-2.; Rajamani AS, Rammohan A, Sai VVR, et al. Current techniques and future trends in the diagnosis of hepatic steatosis in liver donors: A review Journal of Liver Transplantation. 2022; 7:100091. DOI:10.1016/j.liver.2022.100091.; Rastogi R, Gupta S, Garg B, et al. Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors. Indian J Radiol Imaging. 2016; 26(1):5–14. DOI:10.4103/0971-3026.178281.; Zhang Y, Wang C, Duanmu Y, et al. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol. 2018; 91(1091):20170587. DOI:10.1259/bjr.20170587.; Zhang PP, Choi HH, Ohliger MA. Detection of fatty liver using virtual non-contrast dual-energy CT. Abdom Radiol (NY). 2022; 47(6):2046–2056. DOI:10.1007/s00261-022-03482-9.; Zhang YN, Fowler KJ, Hamilton G, et al. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol. 2018; 91(1089):20170959. DOI:10.1259/bjr.20170959.; Lamb P, Sahani DV, Fuentes-Orrego JM, et al. Stratification of patients with liver fibrosis using dualenergy CT. IEEE Trans Med Imaging. 2015; 34(3):807–815. DOI:10.1109/TMI.2014.2353044.; Аллахвердиева Я.С., Воробьев С.В., Минеев Н.И. Современные возможности магнитно-резонансных технологий в диагностике ожирения печени. Медицинский вестник Северного Кавказа. 2018; 13(4):695–700. DOI:10.14300/mnnc.2018.13140.; Jayakumar S, Middleton MS, Lawitz EJ, et al. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. J Hepatol. 2019; 70(1):133–141. DOI:10.1016/j.jhep.2018.09.024.; Caussy C, Reeder SB, Sirlin CB, et al. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology. 2018; 68(2):763–772. DOI:10.1002/hep.29797.; Gu J, Liu S, Du S, et al. Diagnostic value of MRIPDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 2019; 29(7):3564–3573. DOI:10.1007/s00330-019-06072-4.; Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013; 267(2):422–431. DOI:10.1148/radiol.12120896.; Bonekamp S, Tang A, Mashhood A, et al. Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging. 2014; 39(6):1525–1532. DOI:10.1002/jmri.24321.; Yoneda M, Honda Y, Ogawa Y, et al. Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. BMJ Open Diabetes Res Care. 2021; 9(1):e001990. DOI:10.1136/bmjdrc-2020-001990.; Doycheva I, Cui J, Nguyen P, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther. 2016; 43(1):83–95. DOI:10.1111/apt.13405.; Simchick G, Zhao R, Hamilton G, et al. Spectroscopy-based multi-parametric quantification in subjects with liver iron overload at 1.5T and 3T. Magn Reson Med. 2022; 87(2):597–613. DOI:10.1002/mrm.29021.; Шария М.А., Ширяев Г.А., Устюжанин Д.В. Протонная магнитно-резонансная спектроскопия в диагностическом алгоритме у пациента с неалкогольной жировой болезнью печени при комплексном подходе к лечению. REJR. 2014; 4(3): 91–93.; Yokoo T, Serai SD, Pirasteh A, et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology. 2018; 286(2):486–498. DOI:10.1148/radiol.2017170550.; Roumans KHM, Lindeboom L, Veeraiah P, et al. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nat. Commun. 2020; 11:1891. DOI:10.1038/s41467-020-15684-0.; Trout AT, Serai S, Mahley AD, et al. Liver Stiffness Measurements with MR Elastography: Agreement and Repeatability across Imaging Systems, Field Strengths, and Pulse Sequences. Radiology. 2016; 281(3):793–804. DOI:10.1148/radiol.2016160209.; Serai SD, Obuchowski NA, Venkatesh SK, et al. Repeatability of MR Elastography of Liver: A Meta-Analysis. Radiology. 2017; 285(1):92–100. DOI:10.1148/radiol.2017161398.; Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol. 2014; 20(31):10851–10863. DOI:10.3748/wjg.v20.i31.10851.; Kim BH, Lee JM, Lee YJ, et al. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging. 2011; 34(5):1110–1116. DOI:10.1002/jmri.22723.; Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(23):7392–7402. DOI:10.3748/wjg.v20.i23.7392.; Imajo K, Kessoku T, Honda Y, et al. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology. 2016; 150(3):626–637.e7. DOI:10.1053/j.gastro.2015.11.048.; https://transmed.almazovcentre.ru/jour/article/view/849
-
4Academic Journal
المؤلفون: Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, S. S. Bagnenko, Ю. Н. Савченков, Г. Е. Труфанов, В. А. Фокин, С. С. Багненко
المصدر: Translational Medicine; Том 3, № 5 (2016); 75-81 ; Трансляционная медицина; Том 3, № 5 (2016); 75-81 ; 2410-5155 ; 2311-4495 ; 10.18705/2311-4495-2016-3-5
مصطلحات موضوعية: печень, magnetic resonance imaging, metastasis, pancreatic cancer, colorectal cancer, diffusion weighted imaging, abdominal lymph nodes diffusion, signal intensity, магнитно-резонансная томография, метастазы
وصف الملف: application/pdf
Relation: https://transmed.almazovcentre.ru/jour/article/view/228/222; Nikulin MP, Selchuk VYu, Chistyakov SS, Ibragimov T F. Pancreatic cancer. Bulletin of RONC n.a. N.N. Blokhin RAMS. 2006; 17(3) (app 1): 61. In Russian [Никулин М.П., Сельчук В.Ю., Чистяков С.С., И брагимов Т .Ф., Т итова Г .В. Рак поджелудочной железы. Вестник РО НЦ им. Н.Н.Блохина РА МН. 2006; 17(3) (прил.1): 61].; Vishnevskiy VA, Efanov MG, Paklina O V et al. Anatomic segmental resection for metastases of colorectal cancer to the liver. Annals of surgical Hepatol. 2010; 15(3): 48–57. In Russian [Вишневский В.А., Ефанов М.Г., Паклина О .В. и др. Анатомические сегментарные резекции при метастазах колоректального рака в печень. Анналы хирургической гепатологии. 2010; 15(3): 48–57].; Viganò L, Ferrero A, Lo T esoriere R, Capussotti L. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg O ncol. 2008; 15(9):2458-64.; Einstein A, Smolukhovskiy M.M. Brownian motion. Collect. of articles. (transl. from gem. and french). 1936: 608. In Russian [Эйнштейн А ., Смолуховский М.М. Броуновское движение. Сборник статей [перевод с нем. и франц.]. 1936: 608].; Hahn EL. Spin echoes. Phys. Rev. 1950; 80:580-594.; Stejskal EO. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965; 42:288-292.; Stejskal EO, T anner J. U se of spin echo in pulsed magnetic field gradient to study anisotropic restricted diffusion and flow. J. Chem. Phys. 1965; 43:3579-3603.; Sun X J, Quan X Y, Fan-Heng FH et al. Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J. Gastroenterol. 2008; 11(41):6535-6537.; https://transmed.almazovcentre.ru/jour/article/view/228